Source comparison
Cartalax vs Epithalon: Side-by-Side Comparison
Before selecting a peptide for your research protocol, compare their distinct mechanisms and applications. Amino Acid Sequence Ala-Glu-Asp-Gly Identical sequence. Biological activity determined by tissue-specific receptor binding, not structure alone Primary M
This comparison does not assign a generated winner or score.
- Before selecting a peptide for your research protocol, compare their distinct mechanisms and applications.
- Amino Acid Sequence
- Ala-Glu-Asp-Gly
- Identical sequence. Biological activity determined by tissue-specific receptor binding, not structure alone
- Primary Mechanism
- Chromatin binding and gene expression modulation in gastrointestinal tissue
- Telomerase activation and pineal melatonin stimulation
- Cartalax regulates existing cellular function; Epithalon extends replicative lifespan
- Tissue Specificity
- Gastric and intestinal epithelial cells
- Systemic (pineal gland, immune cells, multiple somatic tissues)
- Cartalax is organ-targeted; Epithalon acts broadly across cell types
- Measurable Endpoints
- Gastric mucosa thickness, protein synthesis markers, ulcer healing rate
- Telomere length, telomerase activity, circadian rhythm markers, lifespan extension
- Choose based on your experimental hypothesis. Endpoints do not overlap
- Typical Dosing Protocol
- 10–20 mcg/day for 10–20 days
- 5–10 mg/day for 20–30 days or cyclical dosing
- Epithalon requires significantly higher doses and longer administration periods
- Reconstituted Stability
- 28 days at 2–8°C
- Both degrade rapidly at room temperature. Cold chain management is critical